SCHEMBL5480307

SCHEMBL5480307

[2H]C1c2cc(OC)c(S(=O)(=O)F)cc2CCN(C)C1[2H]

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.46
MAOB P27338 2/20 0.46
SLC6A4 P31645 1/20 0.46
PDE4D Q08499 3/20 0.42
DRD1 P21728 3/20 0.41
DRD5 P21918 3/20 0.41
DRD4 P21917 2/20 0.41
CA7 P43166 1/20 0.41
DRD2 P14416 3/20 0.41
DRD3 P35462 3/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR6 P50406 1/20 0.41
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 2/20 0.39
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3897270 0.89 MAOA (0.56) MAOAMAOBSLC6A4PDE4DDRD1
SCHEMBL3896970 0.76 MAOA (0.49) MAOAMAOBSLC6A4PDE4DCA7
Hydrochloric Acid SCHEMBL10350988 0.75 MAOA (0.56) MAOAMAOBSLC6A4PDE4DDRD1
SCHEMBL3906143 0.75 MAOA (0.56) MAOAMAOBSLC6A4PDE4DDRD1
SCHEMBL3900962 0.75 MAOA (0.56) MAOAMAOBSLC6A4PDE4DDRD1
SCHEMBL6248353 0.74 ALDH1A1 (0.45) MAOAMAOBSLC6A4PDE4DMEN1
SCHEMBL3907217 0.72 ESR1 (0.55) PDE4DCA7MEN1KMT2A
SCHEMBL3903162 0.70 MAOB (0.48) MAOAMAOBSLC6A4DRD1DRD5
SCHEMBL11169272 0.70 MAOA (0.84) MAOAMAOBSLC6A4PDE4DDRD1
SCHEMBL3907654 0.69 ESR1 (0.61) CA7MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093473-A1 7-Heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents GLAXO GROUP LIMITED 2007-04-26 US disclosed
EP-1663248-A1 7-HETEROARYLSULFONYL-TETRAHYDRO-3-BENZAZEPINE DERIVATIVES AS ANTIPSYCHOTIC AGENTS GLAXO GROUP LIMITED (GB) 2006-06-07 EP disclosed
WO-2005025576-A1 7-HETEROARYLSULFONYL-TETRAHYDRO-3-BENZAZEPINE DERIVATIVES AS ANTIPSYCHOTIC AGENTS GLAXO GROUP LIMITED (GB) 2005-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093473-A1 7-Heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents SIGMAR1, CHRNA3, CHRNA5 MAOA 630/4885MAOB 444/4885SLC6A4 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.